Notably, the coincident dysregulation observed in both melanogenesis and IL-17 signaling pathways in the depigmented skin lesions of Ets-1 KO mice supports the applicability of this model for studying vitiligo pathomechanisms and developing therapeutics strategies. The gene discussed is ETS1; the disease is vitiligo.